Literature DB >> 17674191

COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells.

François Le Dily1, Raphaël Métivier, Marie-Madeleine Guéguen, Christine Le Péron, Gilles Flouriot, Patrick Tas, Farzad Pakdel.   

Abstract

We previously showed that COUP-TFI interacts with the Estrogen Receptor alpha (ER alpha) to recruit Extracellular signal Regulated Kinases (ERKs) in an Estradiol (E2)-independent manner, resulting in an enhancement of ER alpha transcriptional activity. However, the involvement of COUP-TFI in physiologically relevant functions of ER alpha, such as the mitogenic activity that E2 has on breast cancer cells, remains poorly understood. Here, we first showed that the amounts of COUP-TFI protein are higher in dedifferentiated mammary cell lines (MDA-MB-231) and tumor breast cells as compared to the differentiated MCF-7 cell line and normal breast cells. To evaluate the functional relevance of the COUP-TFI/ER alpha interplay in mammary cells, we generated MCF-7 cells that stably over-express COUP-TFI. We found that the over-expression of COUP-TFI enhances motility and invasiveness of MCF-7 cells. COUP-TFI also promotes the proliferation of MCF-7 cells through ER alpha-dependent mechanisms that target cell cycle progression and cell survival. To further investigate the mechanisms underlying these effects of COUP-TFI, we evaluated the expression of known E2-target genes in breast cancer, and found that COUP-TFI differentially regulated genes involved in cell proliferation, apoptosis, and migration/invasion. Notably, Cathepsin D (CTSD) transcript and protein levels were significantly higher in presence and absence of E2 in MCF-7 over-expressing COUP-TFI. Chromatin Immunoprecipitation assays showed that ER alpha, phospho-RNA Polymerase II, as well as p68 RNA Helicase, a phospho-Serine 118 dependent co-activator of ER alpha, were preferentially recruited onto the CTSD gene proximal promoter in COUP-TFI over-expressing cells. These results suggest that COUP-TFI selectively regulates the expression of endogenous E2-target genes and consequently modifies ER alpha positive mammary cells response to E2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674191     DOI: 10.1007/s10549-007-9693-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

Review 1.  P68 RNA helicase as a molecular target for cancer therapy.

Authors:  Ting-Yu Dai; Liu Cao; Zi-Chen Yang; Ya-Shu Li; Li Tan; Xin-Ze Ran; Chun-Meng Shi
Journal:  J Exp Clin Cancer Res       Date:  2014-08-24

2.  Orphan nuclear receptor COUP-TFII is an oncogenic gene in renal cell carcinoma.

Authors:  X Fang; C-X Liu; X-R Zeng; X-M Huang; W-L Chen; Y Wang; F Ai
Journal:  Clin Transl Oncol       Date:  2019-07-31       Impact factor: 3.405

Review 3.  Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.

Authors:  Rebecca B Riggins; Mary M Mazzotta; Omar Z Maniya; Robert Clarke
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

Review 4.  Coup d'Etat: an orphan takes control.

Authors:  Fu-Jung Lin; Jun Qin; Ke Tang; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Endocr Rev       Date:  2011-01-21       Impact factor: 19.871

5.  Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression.

Authors:  Cecilia Williams; Luisa Helguero; Karin Edvardsson; Lars-Arne Haldosén; Jan-Ake Gustafsson
Journal:  Breast Cancer Res       Date:  2009-05-08       Impact factor: 6.466

Review 6.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02

7.  Expression and functional pathway analysis of nuclear receptor NR2F2 in ovarian cancer.

Authors:  Shannon M Hawkins; Holli A Loomans; Ying-Wooi Wan; Triparna Ghosh-Choudhury; Donna Coffey; Weimin Xiao; Zhandong Liu; Haleh Sangi-Haghpeykar; Matthew L Anderson
Journal:  J Clin Endocrinol Metab       Date:  2013-05-20       Impact factor: 5.958

8.  Genome-wide analysis of androgen receptor targets reveals COUP-TF1 as a novel player in human prostate cancer.

Authors:  Ruth Perets; Tommy Kaplan; Ilan Stein; Guy Hidas; Shay Tayeb; Eti Avraham; Yinon Ben-Neriah; Itamar Simon; Eli Pikarsky
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

9.  2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.

Authors:  Lokesh D Nagaprashantha; Jyotsana Singhal; Shireen Chikara; Gabriel Gugiu; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  J Proteomics       Date:  2018-09-21       Impact factor: 4.044

Review 10.  Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer.

Authors:  Reidun Aesoy; Colin D Clyne; Ashwini L Chand
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.